Adaptimmune Therapeutics Plc
$10.00
Adaptimmune (AI) is a clinical-stage biopharmaceutical firm. It focuses on providing novel cell therapies using its proprietary SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell, to patients who are suffering from solid tumors.
“Adaptimmune Therapeutics Plc Analysis ” solution has 1000 words and comprises –
- Overview
- PESTEL Analysis
- Political Factors
- Economic Factors
- Social Factors
- Technological Factors
- Environmental Factors
- Legal Factors
Adaptimmune (AI) is a clinical-stage biopharmaceutical firm. It focuses on providing novel cell therapies using its proprietary SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell, to patients who are suffering from solid tumors.
“Adaptimmune Therapeutics Plc Analysis ” solution has 1000 words and comprises –
- Overview
- PESTEL Analysis
- Political Factors
- Economic Factors
- Social Factors
- Technological Factors
- Environmental Factors
- Legal Factors
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.